Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05989009Completed

Analysis of Lipids in Human Milk At Different Gestational Ages

Role: lead

NCT06052592Completed

Metabolomic Profile in Breastfed Late Preterm Infants

Role: lead

NCT05958251Completed

The Use of Arnica Montana in the Cicatrization of the Umbilical Cord

Role: lead

NCT05986994Unknown

Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy

Role: lead

NCT01379651Phase 1Completed

Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy

Role: lead

All 5 trials loaded